The ELAVL1 gene in MDD patients was also found to be enriched in pathways such as cellular senescence, adipocytokine signaling pathway, glucagon signaling pathway, and insulin resistance, indicating its association with metabolic disorders in depressive patients. Here, ELAVL1 is linked to major depressive disorder.